Image-guided therapy developer ViewRay has received $30 million in funding aimed at supporting worldwide commercialization of its MRI-guided radiation therapy system.
Funds were received from existing equity investors (Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, and OrbiMed Advisors), a new investor (Cowealth Medical Holding), and debt financing provided by specialty finance company Hercules Technology Growth Capital, according to ViewRay.
The ViewRay system has already been purchased by five cancer treatment centers worldwide, the company said.
